253 related articles for article (PubMed ID: 902377)
1. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
Mikulic E; Cohn JN; Franciosa JA
Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
Pomer S; Elert O; Sarai K; Satter P
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy--a comparative study with dobutamine and sodium nitroprusside.
Baumann G; Felix S; Sattelberger U; Klein G
J Cardiovasc Pharmacol; 1990 Jul; 16(1):93-100. PubMed ID: 1696672
[TBL] [Abstract][Full Text] [Related]
4. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
[TBL] [Abstract][Full Text] [Related]
5. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
[No Abstract] [Full Text] [Related]
6. Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
Sabbah HN; Levine TB; Gheorghiade M; Kono T; Goldstein S
Cardiovasc Drugs Ther; 1993 Jun; 7(3):349-56. PubMed ID: 8395876
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic equivalence of automated nitroglycerin- and nitroprusside-infusions combined with dobutamine for augmentation of cardiac output in patients following aorta coronary bypass-operation.
Pomer S; Sarai K; Krause E; Satter P
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):602-7. PubMed ID: 6437993
[TBL] [Abstract][Full Text] [Related]
8. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
9. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
Stemple DR; Kleiman JH; Harrison DC
Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
[TBL] [Abstract][Full Text] [Related]
10. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
Leier CV; Webel J; Bush CA
Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803
[TBL] [Abstract][Full Text] [Related]
11. Circulatory response to vasodilator therapy in congestive cardiomyopathy.
Rossen RM; Alderman EL; Harrison DC
Br Heart J; 1976 Jul; 38(7):695-700. PubMed ID: 973893
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
[TBL] [Abstract][Full Text] [Related]
13. Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction.
Miller RR; Awan NA; Joye JA; Maxwell KS; DeMaria AN; Amsterdam EA; Mason DT
Circulation; 1977 Jun; 55(6):881-4. PubMed ID: 858184
[TBL] [Abstract][Full Text] [Related]
14. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
15. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
[TBL] [Abstract][Full Text] [Related]
16. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
Leier CV; Heban PT; Huss P; Bush CA; Lewis RP
Circulation; 1978 Sep; 58(3 Pt 1):466-75. PubMed ID: 679437
[TBL] [Abstract][Full Text] [Related]
17. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
Massie BM; Cornyn J; Topic N; Loge D; Podolin RA
Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure.
Franciosa JA; Cohn JN
Am J Cardiol; 1979 Jan; 43(1):79-85. PubMed ID: 758774
[No Abstract] [Full Text] [Related]
19. Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
Loeb HS; Bredakis J; Gunner RM
Circulation; 1977 Feb; 55(2):375-8. PubMed ID: 318933
[TBL] [Abstract][Full Text] [Related]
20. Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure.
Coddens J; Delooft T; Vandenbroucke G
J Cardiothorac Vasc Anesth; 1993 Jun; 7(3):321-5. PubMed ID: 8518380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
